Table 3 |
|||
|
Association between maspin expression and clinicopathological factors in triple-negative breast cancer |
|||
|
Maspin expression |
|||
|
|
|||
|
Positive (85.9%) 116 cases |
Negative (14.1%) 19 cases |
P-value |
|
|
|
|||
|
Age (years) |
|||
|
≤50 |
50 |
1 |
0.0015 |
|
>50 |
66 |
18 |
|
|
Tumor size (mm) |
|||
|
≤20 |
41 |
3 |
0.091 |
|
>20 |
75 |
16 |
|
|
Lymph node metastases |
|||
|
0 |
69 |
13 |
0.226 |
|
1-3 |
27 |
1 |
|
|
3< |
20 |
4 |
|
|
Histological grade |
|||
|
I |
4 |
1 |
0.0013 |
|
II |
19 |
10 |
|
|
III |
93 |
8 |
|
|
EGFR |
|||
|
Positive |
57 |
9 |
0.886 |
|
Negative |
59 |
10 |
|
|
CK5/6 |
|||
|
Positive |
77 |
3 |
<0.0001 |
|
Negative |
39 |
16 |
|
|
CK14 |
|||
|
Positive |
45 |
1 |
0.0034 |
|
Negative |
71 |
18 |
|
|
CD10 |
|||
|
Positive |
19 |
5 |
0.293 |
|
Negative |
97 |
14 |
|
|
p63 |
|||
|
Positive |
15 |
2 |
0.769 |
|
Negative |
101 |
17 |
|
|
|
|||
|
Umekita et al. Diagnostic Pathology 2011 6:36 doi:10.1186/1746-1596-6-36 |
|||
